4[6]Ackah AN,Coulibaly D,Digbeu H,et al.Response to treatment,mortality,and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan,Cte dIvoire.Lancet,1995,345:607-610
5[7]USA CDC guideline:Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus:principles of therapy and revised recommendations.MMWR,1998:47
6[2]Perriens JH,Colebunders RL,Karahunga C,et al.Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa,Zaire.Am Rev Respir Dis,1991,144:750-755
7[5]Burack JH,Hahn JA,Saint-Maurice D,et al.Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection:implications for rational empiric antibiotic therapy.Arch Intern Med,1994,154:2589-2596
8[8]Heylen R,Miller R.Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.Genitourinary Medicine,1996,72:237-246
9[9]Tseng AL,Foisy MM.Management of drug interactions in patients with HIV.Ann Pharmacother,1997,31:1040-1058
10[10]Jhon G,Bartlett MD,Joel E,et al.Medical management of HIV infection.Johns Hopkins Univeisity,2000:173-299
